Medtech 2026: Diabetes Care, Nyxoah, FDA Top Most-Read Stories List

 
• By Elizabeth Orr
  
perspectives 2026
This year's two most-read Medtech Insight stories were about Dexcom's 15-day sensor, which the FDA cleared amid an ongoing Warning Letter resolution. (Wright Studio/Shutterstock)

More from Medtech Insight

More from US FDA Warning Letters